Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, the first such authorization for nicotine pouches in the country. The authorized products pose lower risk of cancer and other serious health conditions than cigarettes and most smokeless tobacco products,